Parenteral drugs: FDA replaces guidance on aluminum content limits
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingChemistry, Manufacturing and Controls (CMC)ComplianceContaminantsManufacturingNutritional/Natural HealthPharmaceuticalsQuality Assurance and ControlShortagesSterile drugsUnited StatesUS Food and Drug Administration (FDA)